Nanalysis Scientific Corp. Price & Performance (NSCIF)

Nanalysis Scientific Corp. will hold its first quarter 2025 earnings call on May 28 at 5:00 PM ET, led by CEO Sean Krakiwsky and CFO Randall McRae. A separate European Q&A session follows on May 29. The company continues to target global growth in both scientific equipment and security services.12

Nanalysis reported record annual revenue of $45 million in 2024, up 60% year-over-year. Gross margins improved in both product sales (53%) and services (12%), driven by cost efficiencies and operational improvements. The firm also achieved positive adjusted EBITDA and operating cash flow, reflecting a turnaround from prior losses.34

Despite notable revenue and margin gains, Nanalysis Scientific shares remain under pressure, trading at CA$0.26—near their 52-week low and down nearly 47% year-over-year. The company’s stock continues to underperform both the Canadian medical equipment sector and the broader market, reflecting investor caution amid ongoing net losses and debt concerns.5